153 related articles for article (PubMed ID: 18179962)
1. Myelodysplastic syndromes: introduction.
Sloand EM
Semin Hematol; 2008 Jan; 45(1):1-2. PubMed ID: 18179962
[No Abstract] [Full Text] [Related]
2. How I treat patients with myelodysplastic syndromes.
Stone RM
Blood; 2009 Jun; 113(25):6296-303. PubMed ID: 19383969
[No Abstract] [Full Text] [Related]
3. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management.
Garcia-Manero G
Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090
[TBL] [Abstract][Full Text] [Related]
4. Update on the pharmacotherapy for myelodysplastic syndromes.
Duong VH; Komrokji RS; List AF
Expert Opin Pharmacother; 2014 Sep; 15(13):1811-25. PubMed ID: 25080144
[TBL] [Abstract][Full Text] [Related]
5. Optimal sequencing of treatments for patients with myelodysplastic syndromes.
Itzykson R; Fenaux P
Curr Opin Hematol; 2009 Mar; 16(2):77-83. PubMed ID: 19468268
[TBL] [Abstract][Full Text] [Related]
6. Management of myelodysplastic syndromes: 2008 update.
Scott BL; Estey E
Oncology (Williston Park); 2008 Nov; 22(12):1344-52. PubMed ID: 19086598
[TBL] [Abstract][Full Text] [Related]
7. [Myelodysplastic syndromes: therapeutic advances and promising future].
Nomdedeu B
Med Clin (Barc); 2008 Oct; 131(13):500-2. PubMed ID: 19007578
[No Abstract] [Full Text] [Related]
8. New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide.
Loiseau C; Ali A; Itzykson R
Exp Hematol; 2015 Aug; 43(8):661-72. PubMed ID: 26123365
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndrome: An update on diagnosis and therapy.
Koppel A; Schiller G
Curr Hematol Malig Rep; 2009 Jan; 4(1):10-6. PubMed ID: 20425433
[TBL] [Abstract][Full Text] [Related]
10. Management of myelodysplastic syndromes in the geriatric patient.
Ritchie EK; Lachs MS
Curr Hematol Malig Rep; 2009 Jan; 4(1):3-9. PubMed ID: 20425432
[TBL] [Abstract][Full Text] [Related]
11. The myelodysplastic syndromes: the era of understanding.
Meers S
Eur J Haematol; 2015 May; 94(5):379-90. PubMed ID: 25186093
[TBL] [Abstract][Full Text] [Related]
12. Does early diagnosis and treatment of myelodysplastic syndromes make a difference?
Steensma DP
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101099. PubMed ID: 31779983
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy.
Stone R; Sekeres M; Garcia-Manero G; Lyons RM
Clin Adv Hematol Oncol; 2008 Dec; 6(12):1-15. PubMed ID: 19385003
[TBL] [Abstract][Full Text] [Related]
14. JSH Guideline for Tumors of Hematopoietic and Lymphoid Tissues: Leukemia: 6. Myelodysplastic syndromes (MDS).
Miyazaki Y
Int J Hematol; 2017 Aug; 106(2):151-159. PubMed ID: 28677111
[No Abstract] [Full Text] [Related]
15. [Myelodysplastic syndrome. What can be achieved with supportive therapy and new approaches].
Bischoff M
MMW Fortschr Med; 2011 Nov; 153(44):18. PubMed ID: 22111164
[No Abstract] [Full Text] [Related]
16. Myelodysplastic syndrome.
Wells RA; Buckstein R; Rezmovitz J
CMAJ; 2016 Jul; 188(10):751. PubMed ID: 26728842
[No Abstract] [Full Text] [Related]
17. [Treatment of MDS].
Usuki K
Rinsho Ketsueki; 2014 Oct; 55(10):1882-92. PubMed ID: 25297752
[No Abstract] [Full Text] [Related]
18. Myelodysplastic syndromes: therapy and outlook.
Lyons RM
Am J Med; 2012 Jul; 125(7 Suppl):S18-23. PubMed ID: 22735747
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplasia: the good, the fair and the ugly.
Schiffer CA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):49-55. PubMed ID: 17336254
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes (MDS).
Klimek V
Best Pract Res Clin Haematol; 2015 Mar; 28(1):1-2. PubMed ID: 25659724
[No Abstract] [Full Text] [Related]
[Next] [New Search]
